Related Experiment Videos
Modulation of adrenal cell functions by cadmium salts: 3. Sites affected by CdCl2 during stimulated steroid synthesis
O P Mgbonyebi1, C T Smothers, J J Mrotek
1Physiology Department, Meharry Medical College, Nashville, TN 37208.
Abstract:
In previous studies cadmium chloride (CdCl2) nonlethally inhibited Y-1 mouse adrenal tumor cell 20-dihydroxyprogesterone (20DHP) secretion, affecting unstimulated and stimulated steroidogenic pathway sites differently. In addition, dibutyryl cAMP-stimulated 20DHP secretion was unaffected by CdCl2, while the site of the unstimulated effect was indirectly shown to involve steps between endogenous cholesterol utilization and 20-hydroxycholesterol association with mitochondrial cytochrome P450 side-chain cleavage enzyme. In the present study we determined CdCl2 effects on plasma membrane sites preceding pre-dbcAMP-stimulation of 20DHP secretion. Y-1 cells were incubated 0.5 h in medium with or without cadmium (using the concentration that inhibited adrenocorticotropin- (ACTH)-stimulated steroid secretion by 50%) together with exogenously added maximally stimulating concentrations of ACTH, cholera toxin, forskolin, or adenosine triphosphate. Cholera toxin, forskolin and ATP bypass specific plasma membrane sites involved in the synthesis of intracellular cAMP and activate the steroid hormone biosynthetic pathway. Cadmium effects on ACTH-stimulated endogenous cAMP secretion were also examined. CdCl2 significantly reduced Y-1 cell 20DHP secretion following exposure to ACTH, cholera toxin, forskolin, and ATP; it also significantly decreased endogenous cAMP secretion into culture medium. These data may be interpreted to suggest that CdCl2 altered Y-1 cell regulation of adenyl cyclase activity, which reduced cAMP-activated cholesterol uptake by mitochondria as a consequence.
Insights
Cadmium chloride (CdCl2) inhibits steroid secretion in Y-1 cells by affecting adenyl cyclase activity and reducing cyclic AMP (cAMP) levels. This impacts cholesterol uptake by mitochondria, ultimately decreasing 20-dihydroxyprogesterone (20DHP) secretion.
Area of Science:
- Endocrinology
- Cell Biology
- Toxicology
Background:
- Cadmium chloride (CdCl2) previously showed nonlethal inhibition of Y-1 mouse adrenal tumor cell 20-dihydroxyprogesterone (20DHP) secretion.
- CdCl2 affected unstimulated and stimulated steroidogenic pathways differently, with dibutyryl cAMP-stimulated secretion remaining unaffected.
Purpose of the Study:
- To determine CdCl2 effects on plasma membrane sites preceding pre-dibutyryl cAMP stimulation of 20DHP secretion in Y-1 cells.
- To investigate CdCl2's impact on adenyl cyclase activity and subsequent cAMP production.
Main Methods:
- Y-1 cells were incubated with or without cadmium chloride (at 50% inhibitory concentration for ACTH-stimulated secretion).
- Cells were stimulated with adrenocorticotropin (ACTH), cholera toxin, forskolin, or adenosine triphosphate (ATP).
- CdCl2 effects on endogenous cAMP secretion were also measured.
Main Results:
- CdCl2 significantly reduced 20DHP secretion in response to ACTH, cholera toxin, forskolin, and ATP.
- CdCl2 significantly decreased endogenous cAMP secretion into the culture medium.
- These findings suggest CdCl2 interferes with adenyl cyclase regulation.
Conclusions:
- CdCl2 alters Y-1 cell regulation of adenyl cyclase activity.
- This leads to reduced cAMP production, impacting downstream steroidogenesis.
- The study suggests CdCl2 hinders cAMP-activated cholesterol uptake by mitochondria, consequently reducing 20DHP secretion.